TrialNature medicine2022

Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial.

A Stewart Campbell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.